Paradigm Asset Management CO LLC Gilead Sciences, Inc. Transaction History

Paradigm Asset Management CO LLC

$266 Million
Q3 2024

A detailed history of Paradigm Asset Management CO LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Paradigm Asset Management CO LLC holds 18,700 shares of GILD stock, worth $1.76 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares

18,700

Previous 18,700 -0.0%

Holding current value

$1.76 Million

Previous $1.28 Million 22.14%

% of portfolio

0.59%

Previous 0.51%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$63.15 - $72.88 $299,962 - $346,180	-4,750 Reduced 20.26%	18,700 $1.28 Million
Q1 2024 May 13, 2024	SELL	$71.58 - $87.29 $39,369 - $48,009	-550 Reduced 2.29%	23,450 $1.72 Million
Q4 2023 Feb 12, 2024	SELL	$73.27 - $83.09 $51,289 - $58,163	-700 Reduced 2.83%	24,000 $1.94 Million
Q3 2023 Oct 31, 2023	SELL	$73.94 - $80.67 $96,122 - $104,871	-1,300 Reduced 5.0%	24,700 $1.85 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $1.65 Million - $1.88 Million	21,700 Added 504.65%	26,000 $2 Million
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $267,976 - $384,721	4,300 New	4,300 $369,000
Q2 2022 Aug 08, 2022	SELL	$57.72 - $65.01 $259,740 - $292,545	-4,500 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $38,928 - $44,184	-600 Reduced 11.76%	4,500 $326,000
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $40,614 - $43,818	-600 Reduced 10.53%	5,100 $356,000
Q2 2021 Jul 30, 2021	SELL	$63.47 - $69.35 $25,388 - $27,739	-400 Reduced 6.56%	5,700 $392,000
Q1 2021 May 11, 2021	SELL	$60.0 - $68.46 $36,000 - $41,075	-600 Reduced 8.96%	6,100 $394,000
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $487,756 - $555,775	-8,610 Reduced 56.24%	6,700 $390,000
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $155,250 - $195,200	-2,500 Reduced 14.04%	15,310 $967,000
Q2 2020 Aug 11, 2020	SELL	$72.34 - $84.0 $274,892 - $319,200	-3,800 Reduced 17.58%	17,810 $1.37 Million
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $369,517 - $473,298	5,900 Added 37.56%	21,610 $1.62 Million
Q4 2019 Feb 12, 2020	BUY	$61.62 - $67.78 $43,134 - $47,446	700 Added 4.66%	15,710 $1.02 Million
Q3 2019 Nov 15, 2019	SELL	$62.51 - $69.0 $200,032 - $220,800	-3,200 Reduced 17.57%	15,010 $951,000
Q2 2019 Aug 08, 2019	SELL	$61.87 - $69.38 $71,150 - $79,787	-1,150 Reduced 5.94%	18,210 $0
Q1 2019 May 14, 2019	SELL	$62.53 - $70.05 $62,530 - $70,050	-1,000 Reduced 4.91%	19,360 $0
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $1.5 Million - $1.95 Million	-24,700 Reduced 54.82%	20,360 $1.27 Million
Q3 2018 Nov 19, 2018	BUY	$71.28 - $78.92 $302,940 - $335,410	4,250 Added 10.41%	45,060 $0
Q1 2018 May 07, 2018	SELL	$72.84 - $88.8 $189,384 - $230,880	-2,600 Reduced 5.99%	40,810 $0
Q4 2017 Feb 12, 2018	BUY	$71.15 - $83.52 $476,705 - $559,584	6,700 Added 18.25%	43,410 $0
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $2.65 Million - $3.14 Million	36,710	36,710 $0

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Asset Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Asset Management CO LLC with notifications on news.

Account

Paradigm Asset Management CO LLC Gilead Sciences, Inc. Transaction History